CRM
TECH icon

Cramer Rosenthal McGlynn’s Bio-Techne TECH Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7M Buy
774,723
+339,090
+78% +$18.3M 2.77% 7
2026
Q1 		$22.8M Sell
435,633
-218,837
-33% -$13.1M 1.67% 22
2025
Q4 		$38.5M Buy
654,470
+95,281
+17% +$5.79M 2.48% 6
2025
Q3 		$31.1M Buy
559,189
+37,200
+7% +$1.99M 1.94% 14
2025
Q2 		$26.9M Sell
521,989
-41,741
-7% -$2.1M 1.85% 20
2025
Q1 		$33.1M Buy
563,730
+78,213
+16% +$5.3M 2.38% 7
2024
Q4 		$35M Sell
485,517
-11,298
-2% -$830K 1.98% 11
2024
Q3 		$39.7M Buy
496,815
+123,796
+33% +$9.3M 2.2% 7
2024
Q2 		$26.7M Sell
373,019
-7,783
-2% -$573K 1.57% 22
2024
Q1 		$26.8M Buy
380,802
+147,528
+63% +$10.6M 1.45% 29
2023
Q4 		$18M Buy
+233,274
New +$15.4M 0.98% 47
2017
Q1 		– Sell
-1,196,032
Closed -$30.7M – 227
2016
Q4 		$30.7M Sell
1,196,032
-60,116
-5% -$1.58M 0.46% 92
2016
Q3 		$34.4M Buy
1,256,148
+88,620
+8% +$2.43M 0.53% 83
2016
Q2 		$32.9M Sell
1,167,528
-730,420
-38% -$18.8M 0.53% 79
2016
Q1 		$44.8M Sell
1,897,948
-87,540
-4% -$1.93M 0.71% 64
2015
Q4 		$44.7M Sell
1,985,488
-444,732
-18% -$10.1M 0.67% 67
2015
Q3 		$56.2M Buy
2,430,220
+307,384
+14% +$7.71M 0.76% 49
2015
Q2 		$52.3M Sell
2,122,836
-82,740
-4% -$2.07M 0.65% 62
2015
Q1 		$55.3M Sell
2,205,576
-56,040
-2% -$1.33M 0.62% 68
2014
Q4 		$52.2M Buy
2,261,616
+383,040
+20% +$8.77M 0.54% 74
2014
Q3 		$43.9M Sell
1,878,576
-492,424
-21% -$11.5M 0.44% 86
2014
Q2 		$54.9M Sell
2,371,000
-22,080
-0.9% -$488K 0.44% 89
2014
Q1 		$51.1M Buy
2,393,080
+137,260
+6% +$3.09M 0.39% 101
2013
Q4 		$53.4M Sell
2,255,820
-79,360
-3% -$1.72M 0.38% 96
2013
Q3 		$46.7M Sell
2,335,180
-322,120
-12% -$6.11M 0.35% 100
2013
Q2 		$45.9M Buy
+2,657,300
New +$44.1M 0.35% 104

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cramer Rosenthal McGlynn's TECH Position: Q2 2026 in Review

Cramer Rosenthal McGlynn increased its Bio-Techne (TECH) stake by 78% in Q2 2026, buying an estimated $18.3M and bringing the position to 774,723 shares worth $54.7M. The position accounts for 2.77% of the portfolio, ranked #7.

Cramer Rosenthal McGlynn first reported a position in TECH in Q2 2013 and has held it in 26 quarters since. The position peaked at $56.2M in Q3 2015. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cramer Rosenthal McGlynn held 774,723 shares of Bio-Techne worth $54.7M as of Q2 2026.
  • Cramer Rosenthal McGlynn bought 339,090 Bio-Techne shares in Q2 2026, an estimated $18.3M.
  • Bio-Techne made up 2.77% of Cramer Rosenthal McGlynn's portfolio in Q2 2026, its #7 holding.
  • Cramer Rosenthal McGlynn first reported a position in Bio-Techne in Q2 2013 and has held it in 26 quarters since.
  • Cramer Rosenthal McGlynn's Bio-Techne position peaked at $56.2M in Q3 2015.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2026, filed 13 Aug 2026.